{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T21:24:44Z","timestamp":1786310684009,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T00:00:00Z","timestamp":1717286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC128"],"award-info":[{"award-number":["CRC128"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.xcrm.2024.101622","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:34:07Z","timestamp":1719225247000},"page":"101622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy"],"prefix":"10.1016","volume":"5","author":[{"given":"Marie","family":"Deffner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Schneider-Hohendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schulte-Mecklenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ostkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"M\u00fcller-Miny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Cahir-McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran T.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Meyer zu H\u00f6rste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina C.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver M.","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-9885","authenticated-orcid":false,"given":"Nicholas","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101622_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","article-title":"Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease","volume":"17","author":"Cortese","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors","volume":"199","author":"Egli","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ene.12304","article-title":"Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial","volume":"21","author":"Bozic","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awac237","article-title":"Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions","volume":"146","author":"Joly","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101622_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy in HIV-1 infection","volume":"9","author":"Cinque","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s13365-023-01164-w","article-title":"Revisiting JC virus and progressive multifocal leukoencephalopathy","volume":"29","author":"Rocchi","year":"2023","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.xcrm.2024.101622_bib7","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1177\/1352458520970103","article-title":"High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients","volume":"27","author":"Schneider-Hohendorf","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.xcrm.2024.101622_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/WNL.0000000000207622","article-title":"Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy","volume":"101","author":"Schweitzer","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101622_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/13550280152537175","article-title":"JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy","volume":"7","author":"Du Pasquier","year":"2001","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.xcrm.2024.101622_bib10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ana.26020","article-title":"Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy","volume":"89","author":"Berzero","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1474-4422(21)00174-5","article-title":"BK virus-specific T\u00a0cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study","volume":"20","author":"Cortese","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","article-title":"Allogeneic BK Virus\u2013Specific T Cells for Progressive Multifocal Leukoencephalopathy","volume":"379","author":"Muftuoglu","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001020","article-title":"Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy","volume":"8","author":"Hopfner","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2024.101622_bib14","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.xcrm.2024.101622_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106314","article-title":"The role of chemokines and chemokine receptors in multiple sclerosis","volume":"83","author":"Cui","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.xcrm.2024.101622_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11011-020-00648-6","article-title":"A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis","volume":"36","author":"Ghafouri-Fard","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000937","article-title":"The Role of Chemokines during Viral Infection of the CNS","volume":"6","author":"Hosking","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101622_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-015-1391-6","article-title":"High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc","volume":"129","author":"Stork","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.xcrm.2024.101622_bib19","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1084\/jem.20140540","article-title":"VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T\u00a0cells and MCAM-adhesion of TH17 cells","volume":"211","author":"Schneider-Hohendorf","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adc9778","article-title":"A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis","volume":"14","author":"Ostkamp","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.immuni.2020.12.011","article-title":"Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid","volume":"54","author":"Heming","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101622_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","article-title":"Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis","volume":"11","author":"Schafflick","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101622_bib23","article-title":"A structured evaluation of cryopreservation in generating single-cell transcriptomes from cerebrospinal fluid","volume":"3","author":"Touil","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2024.101622_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101622_bib25","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics","author":"Jin","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2024.101622_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1016377","article-title":"Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies","volume":"13","author":"Hatchwell","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jamaneurol.2024.0017","article-title":"Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis","volume":"81","author":"Cross","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib28","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101622_bib29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/biom13081204","article-title":"CXCL10 Is Associated with Increased Cerebrospinal Fluid Immune Cell Infiltration and Disease Duration in Multiple Sclerosis","volume":"13","author":"Blandford","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.xcrm.2024.101622_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01026","article-title":"Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients","volume":"13","author":"Bai","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.xcrm.2024.101622_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101622_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jir387","article-title":"Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden","volume":"204","author":"Spudich","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13550280590924539","article-title":"Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate\u00a0with containment of JC virus and prognosis of acquired immunodeficiency syndrome\u2013associated progressive multifocal leukoencephalopathy","volume":"11","author":"Marzocchetti","year":"2005","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.xcrm.2024.101622_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-5728(01)00261-2","article-title":"Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies","volume":"115","author":"Franciotta","year":"2001","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02751-23","article-title":"Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles","volume":"11","author":"Oberholster","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.xcrm.2024.101622_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jnr.23135","article-title":"Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells","volume":"91","author":"Darbinyan","year":"2013","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.xcrm.2024.101622_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae066","article-title":"Exploring JC Polyomavirus Sequences and Human Gene Expression in Brain Tissue of Patients With Progressive Multifocal Leukoencephalopathy","author":"Honkimaa","year":"2024","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1352458509355068","article-title":"Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid","volume":"16","author":"Mellerg\u00e5rd","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.xcrm.2024.101622_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab229","article-title":"Relapse-independent multiple sclerosis progression under natalizumab","volume":"3","author":"Graf","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.xcrm.2024.101622_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ana.22074","article-title":"Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated","volume":"68","author":"Killestein","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209944120","article-title":"Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound","volume":"120","author":"Janoschka","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101622_bib44","doi-asserted-by":"crossref","first-page":"e1926","DOI":"10.1212\/WNL.0000000000201029","article-title":"Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis","volume":"99","author":"Roos","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101622_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200146","article-title":"Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum","volume":"14","author":"Berek","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/1352458517708464","article-title":"The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing","volume":"24","author":"van Kempen","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.xcrm.2024.101622_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.msard.2019.03.017","article-title":"Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing","volume":"31","author":"Foley","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.xcrm.2024.101622_bib48","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000672","article-title":"Pharmacodynamics of natalizumab extended interval dosing in MS","volume":"7","author":"Zhovtis Ryerson","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2024.101622_bib49","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/brain\/awz301","article-title":"Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis","volume":"142","author":"Herich","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2024.101622_bib50","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000008243","article-title":"Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing","volume":"93","author":"Ryerson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101622_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13550280600716604","article-title":"Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: Co-localization of CD8+ T\u00a0cells with JCV-infected glial cells","volume":"12","author":"W\u00fcthrich","year":"2006","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.xcrm.2024.101622_bib52","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/JVI.75.7.3483-3487.2001","article-title":"JC Virus-Specific Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy","volume":"75","author":"Koralnik","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101622_bib53","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/01.aids.0000194804.97164.86","article-title":"Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies","volume":"19","author":"Du Pasquier","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2024.101622_bib54","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00002030-200307040-00004","article-title":"Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy","volume":"17","author":"Gasnault","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.xcrm.2024.101622_bib55","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.02506-10","article-title":"Role of CD4 + and CD8 + T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome","volume":"85","author":"Gheuens","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101622_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.24574","article-title":"Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant","volume":"79","author":"Jelcic","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib57","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.20042530","article-title":"Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection","volume":"202","author":"Glass","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20051970","article-title":"CCR5 deficiency increases risk of symptomatic West Nile virus infection","volume":"203","author":"Glass","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJICMR.S35953","article-title":"Role of CXCL10 in central nervous system inflammation","volume":"6","author":"McKimmie","year":"2014","journal-title":"Int. J. Interferon Cytokine Mediat. Res."},{"key":"10.1016\/j.xcrm.2024.101622_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2020.101467","article-title":"The lymphocyte populations and their migration into the central nervous system in tick-borne encephalitis","volume":"11","author":"Grygorczuk","year":"2020","journal-title":"Ticks Tick. Borne. Dis."},{"key":"10.1016\/j.xcrm.2024.101622_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte Chemoattractant Protein-1 (MCP-1): An Overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.xcrm.2024.101622_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13073-022-01111-0","article-title":"Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16\/CXCR6 as\u00a0maintenance factors for tissue-resident T\u00a0cells that drive synapse elimination","volume":"14","author":"Rosen","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib63","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","article-title":"CXCR6 orchestrates brain CD8+ T\u00a0cell residency and limits mouse Alzheimer\u2019s disease pathology","volume":"24","author":"Su","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007365","article-title":"CD4 T\u00a0cells control development and maintenance of brain-resident CD8 T\u00a0cells during polyomavirus infection","volume":"14","author":"Mockus","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101622_bib65","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/v15102112","article-title":"Polyomavirus Wakes Up and Chooses Neurovirulence","volume":"15","author":"Butic","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2024.101622_bib66","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.cell.2021.07.015","article-title":"CXCR6 positions cytotoxic T\u00a0cells to receive critical survival signals in the tumor microenvironment","volume":"184","author":"Di Pilato","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101622_bib67","article-title":"CXCR6 by increasing retention of memory CD8+ T\u00a0cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer","volume":"9","author":"Muthuswamy","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2024.101622_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113250","article-title":"In-depth analysis of human virus-specific CD8+ T\u00a0cells delineates unique phenotypic signatures for T\u00a0cell specificity prediction","volume":"42","author":"Schmidt","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101622_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113279","article-title":"T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T\u00a0cells with specificities against immunogenic viral antigens","volume":"42","author":"Chen","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101622_bib70","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","article-title":"Two subsets of stem-like CD8+ memory T\u00a0cell progenitors with distinct fate commitments in humans","volume":"21","author":"Galletti","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib71","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T Cell Exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2024.101622_bib72","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy","volume":"380","author":"Irene","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101622_bib73","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2024.101622_bib74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458511421919","article-title":"Immunological and clinical consequences of treating a patient with natalizumab","volume":"18","author":"Schwab","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.xcrm.2024.101622_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrneurol.2015.248","article-title":"CCR5 blockade for neuroinflammatory diseases \u2014 beyond control of HIV","volume":"12","author":"Martin-Blondel","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2024.101622_bib76","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001097","article-title":"CCR5 Blockade in Inflammatory PML and PML-IRIS Associated\u00a0With Chronic Inflammatory Diseases\u2019 Treatments","volume":"9","author":"Bernard-Valnet","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.xcrm.2024.101622_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.coph.2008.05.002","article-title":"Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved","volume":"8","author":"Savarin","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101622_bib78","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1016\/j.cell.2022.11.019","article-title":"Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment","volume":"185","author":"Piehl","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101622_bib79","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using\u00a0scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2024.101622_bib80","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.xcrm.2024.101622_bib81","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101622_bib82","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1002\/eji.201040558","article-title":"Regulatory T\u00a0cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis","volume":"40","author":"Schneider-Hohendorf","year":"2010","journal-title":"Eur. J. Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:16:00Z","timestamp":1778919360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2666379124003264"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101622","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101622"}}